Next Century Growth Investors’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
RI
WA
CAC
Next Century Growth Investors's XGN Position: Q2 2020 in Review
Next Century Growth Investors sold out of Exagen (XGN) in Q2 2020, closing a stake of 253,288 shares — an estimated $4.04M sold.
Next Century Growth Investors first reported a position in XGN in Q3 2019 and held it in 3 quarters. The position peaked at $6.62M in Q4 2019. 34 funds tracked by Wall St. Rank hold XGN as of Q2 2020.
- Next Century Growth Investors reported no remaining Exagen position as of Q2 2020 after selling out during the quarter.
- Next Century Growth Investors sold 253,288 Exagen shares in Q2 2020, an estimated $4.04M.
- Next Century Growth Investors first reported a position in Exagen in Q3 2019 and held it in 3 quarters.
- Next Century Growth Investors's Exagen position peaked at $6.62M in Q4 2019.
- 34 funds tracked by Wall St. Rank held Exagen as of Q2 2020.
Based on Next Century Growth Investors's 13F filing for Q2 2020, filed 14 Aug 2020.